CEO SUMMARY: William Morice II, MD, PhD, the CEO at Mayo Clinic Laboratories, discusses technology that intrigues him and the important steps clinical laboratory leaders can take to better steer revenue opportunities as they head into the new year. Morice also comments on AI’s growing role in the lab. EDITOR’S NOTE: William Morice II, MD, […]
Insights on Innovative Tech and Running a Clinical Lab in 2026
NEWSMAKER INTERVIEW
- By Scott Wallask
- > From the Volume XXXII, No. 17 - December 8, 2025 Issue
- Tags: Biopharma, Companion diagnostics, Congress, FDA, flow cytometry, genomic sequencing, hematopathologist, Hematopathology, immunoassays, in vitro diagnostics, IVD, laboratory-developed tests, large language models, mass spectrometry, Mayo Clinic Laboratories, next generation sequencing, Paul Friedman MD, people, proteomics, William Morice II MD PhD
